Real-world characteristics and outcomes of patients with intermediate high risk acute pulmonary embolism

Real-world characteristics and outcomes of patients with intermediate high risk acute pulmonary embolism

Background: Exact benefits of currently recommended close monitoring in intermediate high risk acute pulmonary embolism (PE) patients are unknown.
Methods: This prospective observational cohort study determined clinical characteristics, and disease course of intermediate high risk acute PE patients in an academic hospital setting. Frequency of hemodynamic deterioration, use of rescue reperfusion therapy and PE related mortality, were outcomes of interest.
Results: Of 98 intermediate high risk PE patients included for analysis, 81 patients (83%) were closely monitored. Two deteriorated hemodynamically and were treated with rescue reperfusion therapy. One patient survived after this.
Conclusions: In these 98 intermediate high risk PE patients, hemodynamic deterioration occurred in three patients and rescue reperfusion therapy of two closely monitored patients led to survival of one. Underlining the need for better recognition of patients benefitting from and research in the optimal way of close monitoring.

Request Permissions

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center’s (CCC) Marketplace website by clicking the button below:

Get Permission

Real-world characteristics and outcomes of patients with intermediate high risk acute pulmonary embolism

12th June 2023
PMID: 37306130
Authors Affiliations
Audrey J.C Overgaauw Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Lilian J Meijboom Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Josien van Es Department of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.
Erik J. Lust Department of Intensive Care Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Erik H. Serne Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
P.W.B. Nanayakkara Section General & Acute Internal Medicine, Department of Internal Medicine, Amsterdam Public Health Research Institute
Yvo M. Smulders Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Albertus J. Kooter Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Ralf W. Sprengers Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Harm-Jan de Grooth Department of Intensive Care Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Rutger J. Lely Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Abel Thijs Department of Internal Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Anton Vonk Noordegraaf Department of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.
Leo M.A. Heunks Department of Intensive Care Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Paul W.G. Elbers Department of Intensive Care Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Harm-Jan Bogaard Department of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.
Pieter R. Tuinman Department of Intensive Care Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Cardiovascular Sciences, The Netherlands.
Esther J. Nossent Department of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cardiovascular Sciences, Amsterdam, The Netherlands.

Real-world characteristics and outcomes of patients with intermediate high risk acute pulmonary embolism

Cite this article as:

Overgaauw A, Meijboom LJ, van Es J, Lust EJ, Serne EH, Nanayakkara P, Smulders YM, Kooter AJ, Sprengers RW, de Grooth HJ, Lely RJ, Thijs A, Noordegraaf AV, Heunks L, Elbers P, Bogaard HJ, Tuinman PR, Nossent EJ. Real-world characteristics and outcomes of patients with intermediate high risk acute pulmonary embolism. Acute Med. 2023;22(2):61-66. doi: 10.52964/AMJA.0936. PMID: 37306130.

Real-world characteristics and outcomes of patients with intermediate high risk acute pulmonary embolism

Share this article

Click the icon of the social media platform on which you would like to share this article.


Shopping Basket
Scroll to Top